Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 17 Hodgkin Disease 15 Central Nervous System Neoplasms 12 Astrocytoma 8 Oligodendroglioma 7 Brain Neoplasms 7 Gliosarcoma 5 Glioblastoma 5 Glioma 4 Lymphoma, Non-Hodgkin 3 Neurotoxicity Syndromes 2 Lymphoma, Follicular 2 Lymphoma, AIDS-Related 2 Recurrence 1 Radiation Injuries 1 Optic Nerve Glioma 1 Medulloblastoma 1 Lymphoma, Mantle-Cell 1 Intraocular Lymphoma 1 HIV Infections 1 Familial ependymoma 1 Ependymoma 1 Drug-Related Side Effects and Adverse Reactions 1 Ataxia Telangiectasia 1 Ataxia 1

Interventions

Cyclophosphamide 12 Whole-Body Irradiation 10 fludarabine phosphate 9 Rituximab 9 Peripheral Blood Stem Cell Transplantation 9 Cyclosporine 9 Mycophenolic Acid 7 Filgrastim 7 Etoposide 6 Dexamethasone 6 Busulfan 6 Methotrexate 5 Tacrolimus 4 Carboplatin 4 Bortezomib 4 Vorinostat 3 Thiotepa 3 Radiotherapy 3 Lenalidomide 3 Irinotecan 3 Cytarabine 3 Calcium Dobesilate 3 merphos 2 liposomal amphotericin B 2 laromustine 2 ixabepilone 2 entinostat 2 Transplantation 2 Therapeutics 2 Prednisone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Intraocular Lymphoma × Procarbazine × Clear all

NCT00074191 2017-04-21

Protocol-A

OHSU Knight Cancer Institute

Phase 2 Completed

Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡